A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers

NCT01039909 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Subjects were never screened/enrolled

Conditions

Healthy Volunteer
Atrophy, Muscular

Interventions

DRUG: Placebo
DRUG: SRT2104

Sponsor

GlaxoSmithKline